A California-based biotech that was actually covered by All Penny Stocks just last week is on the move yet again. This small cap just announced new data and a patent filing covering the use of JadiCells™ and various therapeutic combinations for the treatment of Chronic Obstructive Pulmonary Failure (COPD), according to the release. Shares of Therapeutic Solutions International Inc. (OTCPK:TSOI) rallied strongly on the news.
Therapeutic Solutions focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces ProJuvenol, a synergistic blend of complex anti-aging ingredients to help promote cellular rejuvenation and healthy functionality, Emvolio, Inc. which develops products that can be used together to attack cancer as different levels, and sandbox dental labs, Inc. consists of dental laboratory to manufacture and fill prescriptions from dentist.
Traders were bullish early on as shares quickly climbed up to $0.1328/share (+32.67%) at the session high. This move is a strong continuation of the success this stock has had over the last month as price continues to inch closer to the 52-week high of $0.1729.